Ricky Quoc Ngo

Array ( [id] => 20336768 [patent_doc_number] => 20250340888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-11-06 [patent_title] => COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION [patent_app_type] => utility [patent_app_number] => 19/268623 [patent_app_country] => US [patent_app_date] => 2025-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 114174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19268623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20309447 [patent_doc_number] => 20250327076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-23 [patent_title] => CHEMICALLY MODIFIED ANTISENSE OLIGONUCLEOTIDES (ASOS) AND COMPOSITIONS FOR RNA EDITING [patent_app_type] => utility [patent_app_number] => 19/254867 [patent_app_country] => US [patent_app_date] => 2025-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26258 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19254867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20818700 [patent_doc_number] => 12674162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-07-07 [patent_title] => Compositions and methods for treatment of kidney disease [patent_app_type] => utility [patent_app_number] => 19/219917 [patent_app_country] => US [patent_app_date] => 2025-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 10 [patent_no_of_words] => 10563 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19219917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179755 [patent_doc_number] => 20250263713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/977518 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179756 [patent_doc_number] => 20250263714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/977579 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179754 [patent_doc_number] => 20250263712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/977470 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179750 [patent_doc_number] => 20250263708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/976043 [patent_app_country] => US [patent_app_date] => 2024-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18976043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179753 [patent_doc_number] => 20250263711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/976156 [patent_app_country] => US [patent_app_date] => 2024-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18976156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179752 [patent_doc_number] => 20250263710 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/976118 [patent_app_country] => US [patent_app_date] => 2024-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18976118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20025203 [patent_doc_number] => 20250163425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-22 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/932078 [patent_app_country] => US [patent_app_date] => 2024-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18932078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19785863 [patent_doc_number] => 20250059542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => CELL DEATH-INDUCING DFFA-LIKE EFFECTOR B (CIDEB) IRNA COMPOSITIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/928880 [patent_app_country] => US [patent_app_date] => 2024-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 93761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18928880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19817007 [patent_doc_number] => 20250075214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => RNAi Agents for Inhibiting Expression of Inhibin Subunit Beta E (INHBE), Pharmaceutical Compositions Thereof, and Methods of Use [patent_app_type] => utility [patent_app_number] => 18/819737 [patent_app_country] => US [patent_app_date] => 2024-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41059 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18819737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19862637 [patent_doc_number] => 20250101423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => ADVANCED RNA TARGETING (ARNATAR) [patent_app_type] => utility [patent_app_number] => 18/791380 [patent_app_country] => US [patent_app_date] => 2024-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18791380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20077750 [patent_doc_number] => 12351803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Restoration of the CFTR function by splicing modulation [patent_app_type] => utility [patent_app_number] => 18/765286 [patent_app_country] => US [patent_app_date] => 2024-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 26 [patent_no_of_words] => 12233 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19916354 [patent_doc_number] => 12291710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-05-06 [patent_title] => Antisense oligonucleotide targeting ATN1 mRNA or pre-mRNA [patent_app_type] => utility [patent_app_number] => 18/741110 [patent_app_country] => US [patent_app_date] => 2024-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24072 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18741110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19778724 [patent_doc_number] => 12227748 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-02-18 [patent_title] => Aptamers for binding to a membrane-based lipid [patent_app_type] => utility [patent_app_number] => 18/646631 [patent_app_country] => US [patent_app_date] => 2024-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9104 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646631 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19615381 [patent_doc_number] => 20240401061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/626889 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118255 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18626889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20179749 [patent_doc_number] => 20250263707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID [patent_app_type] => utility [patent_app_number] => 18/582317 [patent_app_country] => US [patent_app_date] => 2024-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1494 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18582317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19300476 [patent_doc_number] => 20240229045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => APTAMER FOR SPECIFICALLY RECOGNIZING SOLUBLE ST2 PROTEIN AND APPLICATION OF THE SAME [patent_app_type] => utility [patent_app_number] => 18/435472 [patent_app_country] => US [patent_app_date] => 2024-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5019 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20099032 [patent_doc_number] => 20250228968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => TUMOR-INTRINSIC GALECTIN-3 SUPPRESSES MELANOMA METASTASIS [patent_app_type] => utility [patent_app_number] => 18/414857 [patent_app_country] => US [patent_app_date] => 2024-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16396 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18414857 [rel_patent_id] =>[rel_patent_doc_number] =>)